SCHEMBL29318864

SCHEMBL29318864

COc1ccc(COc2c(F)cc(C(=O)NC[C@H]3CC[C@H](C(N)=O)CC3)c(F)c2F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
VCP P55072 1/20 0.42
PDE4A P27815 2/20 0.41
PDE4B Q07343 2/20 0.41
PDE4C Q08493 2/20 0.41
PDE4D Q08499 2/20 0.41
ALDH2 P05091 1/20 0.40
ALDH1A1 P00352 2/20 0.40
GNRHR P30968 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
GSK3B P49841 2/20 0.40
F10 P00742 1/20 0.39
CNR2 P34972 1/20 0.39
HTR4 Q13639 2/20 0.38
CXCR3 P49682 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
MCHR1 Q99705 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30995292 1.00 POLB (0.42) POLBVCPPDE4APDE4BPDE4C
SCHEMBL30970080 0.92 POLB (0.42) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL30995319 0.92 MEN1 (0.44) POLBVCPALDH1A1NPC1RAB9A
SCHEMBL29318841 0.92 POLB (0.42) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL29318839 0.92 MEN1 (0.44) POLBVCPALDH1A1NPC1RAB9A
SCHEMBL27390793 0.91 POLB (0.43) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL29318811 0.91 POLB (0.43) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL30970111 0.90 POLB (0.41) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL29318867 0.90 POLB (0.41) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL27347826 0.89 POLB (0.54) POLBALDH1A1NPC1RAB9AF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders HSD17B13, HSD17B3, HSD17B1 POLB 462/4885VCP 1591/4885PDE4A 1698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.